Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New colchicine-like antiangiogenic agents and their use in cancer and other disorders

Dec. 19, 2002

Calsed launched for NSCLC and SCLC

Dec. 19, 2002

Fox Chase collaborates with Telik to evaluate anticancer compounds

Dec. 19, 2002

Keryx plans pre-IND meeting with FDA for KRX-123

Dec. 19, 2002

Nippon Shinyaku acquires rights to Trisenox in certain Asian countries

Dec. 19, 2002

Zevalin and high-dose BEAM chemotherapy in non-Hodgkin's lymphoma

Dec. 19, 2002

Antitumor effects of CI-1033 in human breast cancer cells

Dec. 18, 2002

GW-572016 effective in model of tamoxifen-resistant breast cancer

Dec. 18, 2002

Targeting the uPA system with antibodies as a new approach to cancer therapy

Dec. 18, 2002

Cell-permeable MOE RNA oligonucleotide with telomerase-inhibitory effects

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...